Sunil Upadhaya

Sunil Upadhaya

Auto-generated profile, based on publicly available information

Sunil Upadhaya

Vidant Roanoke-Chowan Hospital, Ahoskie, NC, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2017 in Journal of Community Hospital Internal Medicine Perspectives
Verified
Journal Article
Open access
SHSamer Al Hadidi
Samer Al Hadidi
SUSunil Upadhaya
Sunil Upadhaya
RSRupal Shastri
Rupal Shastri
ZAZain Alamarat
Zain Alamarat
Background: Use of Electronic Health Records is increasing. Copy-and-paste function is frequently used with higher rates of documentation errors. Studies to determine the nature of such errors are needed.Objectives: Determination of the effect of implementing a dictation system for completing notes on the quality of clinical documentation. We hypothesized that implementation of the dictation system for note writing would decrease the rate of errors in the progress notes as well as decrease the rate of copying and pasting. Design/Methods: A prospective interventional study in inpatient medical service for six months’ duration starting in July 2016. Resident physicians’ charts were reviewed by the attending physician on a daily basis. This study was done in a community based hospital affiliated to a university program. Residents’ physicians included Internal Medicine, Transitional year and Combined Internal Medicine Pediatrics residents. Charts reviewed for hospitalized patients. A total of 54 residents were offered a pre-intervention survey indicating their subjective use of copy/paste function. Response rate of 85.18%. Progress notes were reviewed on a daily basis for residents on their inpatient rotation. A total of 621 notes were reviewed. Results: Percentage of notes copied prior to the intervention was 92.73% which decreased to 49.71% post-intervention (RR of 0.54, 95% CI 0.48 0.60 Z statistic 11.005 with p-value <0.0001). Of the copied notes percentage of errors pre-intervention was 58% with no errors identified post-intervention (RR of 0.005, 95% CI 0.0003 0.0795 Z statistic 3.752 with p-value 0.0002). Most of the errors are from notes copied by the same author (85.8%). The most common documentation error was in the physical examination section. Conclusion: Implementing a dictation system eliminated documentation errors over our six months’ study. Further studies are needed to check long effects of using such systems on documentation errors

3 July 2017 in Journal of Community Hospital Internal Medicine Perspectives
Verified
Journal Article
Open access
SUSunil Upadhaya
Sunil Upadhaya
MBMohd Baig
Mohd Baig
BTBasim Towfiq
Basim Towfiq
SHSamer Al Hadidi
Samer Al Hadidi
Nodular pulmonary amyloidosis is a very rare form of localized amyloidosis involving the lung, with very little known about its nature. It is usually associated with indolent B cell lymphoproliferative disorder and also connective tissue disorders. No definite treatment guideline exists. Many patients respond to chemotherapy with low risk of progression and a ‘wait and watch’ strategy is also considered a valid treatment option. In this report the authors present a case of nodular pulmonary amyloidosis with pulmonary mucosa associated lymphoid tissue (MALT) lymphoma that presented with features of metastatic malignant disease and after definitive diagnosis decided not to undergo treatment.

17 July 2018 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
SBSunil Badami
Sunil Badami
SUSunil Upadhaya
Sunil Upadhaya
RVRavi Kanth Velagapudi
Ravi Kanth Velagapudi
PMPushyami Mikkilineni
Pushyami Mikkilineni
RKRanju Kunwor
Ranju Kunwor
GBGhassan Bachuwa
Ghassan Bachuwa
Background. We performed meta-analysis to gather more evidence regarding clinical-molecular subgroups associated with better overall survival (OS) in advanced melanoma treated with checkpoint inhibitors. Materials and Methods. We performed a systematic search of PubMed, Scopus, Cochrane Library, and clinical trial.gov. Randomized clinical trials that compared a checkpoint inhibitor (nivolumab or pembrolizumab) with investigator choice chemotherapy or ipilimumab were included in our study. Hazard ratios (HR) and confidence interval (CI) were calculated for progression-free survival (PFS) and OS for each subgroup using generic inverse model along with the random effect method. Results. A total of 6 clinical trials were eligible for the meta-analysis. OS was prolonged in wild BRAF subgroup (HR 0.65, 95% CI 0.49-0.85, p 0.002), Programmed cell death subgroup (PD-1+) (HR 0.57, 95% CI 0.41-0.80, p 0.001), and high lactate dehydrogenase (LDH) level subgroup (HR 0.60, 95% CI 0.38-0.95, p 0.03). Similarly, we found increased OS in eastern cooperative oncology group (ECOG) 1, males and age >65 years subgroups. Conclusions. Checkpoint inhibitors significantly increased OS in patients with wild BRAF, positive PD-1, and high LDH. However, results should be interpreted keeping in mind associated significant heterogeneity. The results of this study should help in designing future clinical trials.

1 May 2021 in JACC
Verified
Journal Article
Closed access
SUSunil Upadhaya
Sunil Upadhaya
SMSeethramprasad Madala
Seethramprasad Madala
KTKanchan Tiwari
Kanchan Tiwari

1 May 2021 in JACC
Verified
Journal Article
Closed access
SUSunil Upadhaya
Sunil Upadhaya
SMSeetharamprasad Madala
Seetharamprasad Madala
KTKanchan Tiwari
Kanchan Tiwari